Tenet Healthcare Corporation $THC Shares Acquired by Fox Run Management L.L.C.

Fox Run Management L.L.C. boosted its holdings in shares of Tenet Healthcare Corporation (NYSE:THC) by 538.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,634 shares of the company’s stock after acquiring an additional 7,282 shares during the period. Fox Run Management L.L.C.’s holdings in Tenet Healthcare were worth $1,753,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the business. William B. Walkup & Associates Inc. purchased a new position in Tenet Healthcare during the third quarter worth $32,000. Canada Pension Plan Investment Board acquired a new stake in shares of Tenet Healthcare during the second quarter valued at $35,000. Westside Investment Management Inc. raised its stake in Tenet Healthcare by 100.0% in the 3rd quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock valued at $39,000 after purchasing an additional 96 shares during the last quarter. Trust Co. of Vermont purchased a new position in Tenet Healthcare in the 3rd quarter valued at about $41,000. Finally, True Wealth Design LLC grew its holdings in shares of Tenet Healthcare by 238.2% during the second quarter. True Wealth Design LLC now owns 257 shares of the company’s stock worth $45,000 after buying an additional 181 shares in the last quarter. 95.44% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on THC. JPMorgan Chase & Co. boosted their price target on Tenet Healthcare from $200.00 to $230.00 and gave the company an “overweight” rating in a report on Thursday, November 13th. KeyCorp upped their target price on Tenet Healthcare from $225.00 to $250.00 and gave the company an “overweight” rating in a research note on Thursday, February 12th. Truist Financial lifted their price target on Tenet Healthcare from $240.00 to $270.00 and gave the company a “buy” rating in a report on Tuesday, February 17th. Raymond James Financial set a $245.00 price objective on shares of Tenet Healthcare in a report on Wednesday, October 29th. Finally, Cantor Fitzgerald boosted their target price on shares of Tenet Healthcare from $190.00 to $245.00 and gave the company an “overweight” rating in a report on Wednesday, October 29th. One research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $247.67.

Insider Buying and Selling

In other Tenet Healthcare news, Director Nadja West sold 2,178 shares of the business’s stock in a transaction dated Monday, December 15th. The stock was sold at an average price of $197.47, for a total transaction of $430,089.66. Following the transaction, the director owned 28,480 shares in the company, valued at $5,623,945.60. The trade was a 7.10% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.81% of the stock is owned by company insiders.

Tenet Healthcare Stock Up 1.6%

Shares of NYSE:THC opened at $237.43 on Wednesday. Tenet Healthcare Corporation has a 1 year low of $109.82 and a 1 year high of $237.67. The stock has a 50-day simple moving average of $203.42 and a 200-day simple moving average of $198.69. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.68 and a current ratio of 1.76. The stock has a market capitalization of $20.65 billion, a P/E ratio of 15.33, a PEG ratio of 1.14 and a beta of 1.45.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings data on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.08 by $0.62. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The company had revenue of $5.53 billion during the quarter, compared to the consensus estimate of $5.47 billion. During the same period in the previous year, the firm earned $3.44 earnings per share. Tenet Healthcare’s revenue for the quarter was up 8.9% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Equities analysts forecast that Tenet Healthcare Corporation will post 12.24 earnings per share for the current year.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.